Overview of the global postpartum hemorrhage (PPH) devices market forecast
The number of women dying due to complications associated with pregnancy and childbirth is increasing rapidly globally. Also, women suffering from complications that result in long-lasting sequelae often succumb to maternal death. Complications due to pregnancy such as multiple births, preterm births, and macrosomia increases the risk of PPH. Technavio’s market study identifies the increasing complications and risk factors for PPH to be one of the primary growth factors for the postpartum hemorrhage (PPH) devices market. Risky factor such as uterine atony, trauma, retained placenta, obesity, and bleeding disorders also drive the rising incidences of PPH. Trauma is the leading non-obstetric cause of death whereas uterine atony is the most common cause of severe PPH within 24 hours. According to postpartum hemorrhage devices market forecast, our analysts estimate that the market will grow steadily at a CAGR of more than 5% by 2022.
The increasing focus on the development of low-cost PPH treatment devices is one of the key factors driving the growth of the postpartum hemorrhage devices market size. Hospitals primarily administer uterine balloon tamponade to cure PPH. However, due to the exponentially high cost and single usage, hospitals are sourcing for low-cost alternative PPH treatment devices. Manufacturers are increasingly offering low-cost postpartum hemorrhage treatment devices to drive their adoption and accessibility globally, primarily in developing and low-resource countries.
Companies covered:
The postpartum hemorrhage (PPH) devices market is fragmented owing to the presence of several international and regional numerous vendors. This market report includes information about key companies and their product portfolio. This report also focuses on the competitive environment between the players in the postpartum bleeding market. Technavio’s analysts also analyze the strategies adopted by vendors and the competitive analysis of the postpartum hemorrhage (PPH) devices market.
Our market research analysts identify some of the key companies in the postpartum hemorrhage (PPH) devices market
- BD
- Cook Medical
- C. R. Bard
- Teleflex
- Utah Medical Products
- ZOEX
Segmentation by product type and analysis of the postpartum hemorrhage (PPH) devices market
The uterine balloon tamponade product segment will account for the major share in the postpartum bleeding market throughout the forecast period. However, it is witnessed that this industry segment experiences a steady growth.
Geographical segmentation and analysis of the postpartum hemorrhage (PPH) devices market
The Americas will be the major revenue contributor to the PPH market throughout the forecast period. Factors such as high incidence of PPH, high hospital delivery rate, increase in medical complications related to pregnancy, high awareness among end-users about advanced PPH treatments, advanced healthcare infrastructure, and the increased healthcare expenditure will drive the growth of the postpartum bleeding market in this region.
Key questions answered in the report include
- What will the market size and the growth rate be in 2022?
- What are the key factors driving the global postpartum hemorrhage (PPH) devices market?
- What are the key market trends impacting the growth of the global postpartum hemorrhage (PPH) devices market?
- What are the challenges to market growth?
- Who are the key vendors in the global postpartum hemorrhage (PPH) devices market?
- What are the market opportunities and threats faced by the vendors in the global postpartum hemorrhage (PPH) devices market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global postpartum hemorrhage (PPH) devices market?
Technavio also offers customization on reports based on specific client requirement.